Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex vs Ranibizumab vs Combination for CRVO
NCT01827722Phase 4Unknown
- Sponsor
- Valley Retina Institute
- Start
- May 2013
- Primary completion
- May 2016
- Modality
- Antibody Fragments, Antibody Conjugates, Implantable Devices
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex, ranibizumab in macular edema, sponsored by Valley Retina Institute. Status: unknown.
02
Drugs
ozurdexranibizumab
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01827722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01827722.